- STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsAstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.STAT · 1mo ago↗ source
- STAT+: UnitedHealthcare’s lactation billing feud, and fake strokesThe biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.STAT · 1mo ago↗ source
- STAT+: Novo underwhelmed by drug it once fought Pfizer forRevolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech newsSTAT · 1mo ago↗ source